Tissue ablation: microwave, thermal, hydro and cryo on the rise

Ablation Worldwide Market, 2007 to 2017Technologies for ablation and other energy-based treatments in medical/surgical markets are currently dominated by electrosurgical-type therapies, but a growing array of other modalities are creating new applications or penetrating existing ones.  These modalities include hydromechanical, microwave, thermal, cryotherapy, ultrasound, radiofrequency (RF), light, radiation (radiosurgery, radiotherapy) and electrical.

At right is shown the forecast, by modality type, of ablation and other energy-based therapies through 2017. The most significant growth is expected to come from microwave, thermal, hydromechanical and cryotherapy, each of which will demonstrate compound growth rates in excess of 15% annually.


Excerpt from report #A125, “Ablation Technologies Worldwide Market,” (published September 2008).  See link.  Report #A125, “Ablation Technologies Worldwide”, may be purchased online.

 

 

India’s Growth Market in Ablation Technology

The medical markets inthe Asia/Pacific region show enormous variations in size, due to differences in healthcare expenditure as well as the obvious differing population sizes. Although China and India have vastly greater populations than other countries in the region, it is the Japanese ablation market that takes the largest share of the global market, with an estimated 6.2%. This country’s medical market has been showing a modest (3%) annual growth after a period of stagnation.  However, in terms of absolute growth rate for sals of ablation technology products, India is the leader, edging out even China.

 

Source:  MedMarket Diligence Report #A125, "Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities."  Published September 2008.

 


This MedMarket Diligence report #A125, "Ablation Technologies Worldwide Market," is described in detail here. The report may be purchased for immediate download here.

 

Analysis pending on sealants, glues, wound closure, anti-adhesion

Below is a a report to be published (December 2008) from MedMarket Diligence on the worldwide surgical sealants, glues, wound closure and anti-adhesion market.  The report is described at this link.

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2009-2013

· 225 pages · 60 Exhibits · 79 Company Profiles · Report #S175 · Publishing December 2008

This report details the complete range of sealants & glues technologies used in traumatic, surgical and other wound closure, from tapes, sutures and staples to hemostats, fibrin sealants/glues and medical adhesives. The report details current clinical and technology developments in this huge and rapidly growing worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

This report is a market and technology assessment and forecast of products in wound closure. The report details the current and emerging products, technologies and markets involved in wound closure and sealing using sutures and staples, tapes, hemostats, fibrin and sealant products and medical adhesives. The report provides a worldwide current and annual forecast to 2013 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the coming decade. The report provides specific forecasts and shares of the worldwide market by segment for the U.S., Europe (United Kingdom, German, France, Italy, BeNeLux), Latin America, Japan and Rest of World.

The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

 

(For more information, see link or contact Patrick Driscoll, patrick at mediligence dot com, or tel: 949-859-3401.)

Wound management: established and emerging products, technologies and markets worldwide

Below is a report from MedMarket Diligence on the worldwide wound management market.  The report is described in detail here.

Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World 

· 256 pages · 64 Exhibits · 69 Company Profiles · Report #S245 · Published Nov. 2007

This report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report details current clinical and technology developments in this huge worldwide market with high growth sectors, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments — multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying the huge and evolving worldwide wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced wound care research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

(For more information, see link or contact Patrick Driscoll, patrick at mediligence dot com, or tel: 949-859-3401.)

Products, technologies and markets in spine surgery worldwide

Below is a report from MedMarket Diligence on the worldwide market for spine surgery technologies. The report is described at link.

Spine Surgery Worldwide 2008-2017: Products, Technologies, Markets & Opportunities, Worldwide, 2008-2017

· 380 pages · 190 Exhibits · 98 Company Profiles · Report #M510 · Published March 2008

This report details the complete range of products and technologies in, spine surgery, the surgical management of spine disorders, diseases and trauma, from grafts, demineralized bone, fusion, stabilization, disc replacement, nucleus replacement, vertebroplasty, kyphoplasty, imaging, minimally invasive surgical technologies, energy-based therapies and biologics. The report details current clinical and technology developments in the huge and rapidly growing spine surgery technologies worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

This report is a detailed market and technology assessment and forecast of the products and technologies in the management of diseases and disorders of the spine. The report describes diseases and disorders of the spine, encompassing congenital disorders, inflammatory and infectious diseases; degenerative diseases; herniations, stenoses, myelopathies and other "mechanical" disorders of the spine; spinal trauma; tumors of the spine; and others. The report characterizes the patient populations, their current clinical management, and trends in clinical management as new techniques and technologies are expected to be developed and emerge. The report details the currently available products and technologies, and manufacturer offerings. The report details products and technologies under development and markets for each in spine surgery. The report provides a current and forecast assessment of the worldwide markets for these technologies, with geographic segmentation by U.S. & Canada, European Union (detailing France, United Kingdom, Germany, Italy and Spain), Japan and Rest of World. The report provides emphasis on the market impact of new technologies through the coming decade, profiling nearly 100 active companies in this industry, with comprehensive detail on key companies, providing data on their current products, current market position and products under development.

(For more information, contact Patrick Driscoll, patrick at mediligence dot com, or tel: 949-859-3401.)

Technologies in ablation of soft tissue, worldwide report

Below is a recent MedMarket Diligence report on Ablation Technologies.  The report is described in detail at link.

Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities

· 264 pages · 70 Exhibits · 61 Company Profiles · September 2008 · Report #A125

This report is a detailed market and technology assessment and forecast of the products and technologies in the ablation market for treatment of soft tissues via energy-based modalities, including electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet therapy (hydrotherapy), microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation.

The report describes alternative energy-based technologies and the nature of their effect on soft tissue, the underlying basis of the technology, the requisite systems for their use (including capital equipment, devices and disposables), and their strengths and weaknesses for specific clinical applications. The report details current and anticipated target applications and assesses the current and forecast caseload for each energy-based therapeutic considering competition from any and all alternative energy-based or other therapeutics, with current and worldwide market forecasts (2008-2017) segmented by technology type and specific clinical segment. The report provides segmentation of the worldwide ablation market by both ablation technology and region/country: Americas (USA, Canada, Mexico, Brazil), Europe (Germany, United Kingdom, France, Italy, Spain, BeNeLux), Asia/Pacific (Japan, China, India, Australia) and Rest of World. The report details the current and emerging products, technologies and markets for each energy-based therapy. The report profiles over 60 key companies in this industry detailing their current products, current market position and products under development.

(For more information, contact Patrick Driscoll, patrick at mediligence dot com, or tel: 949-859-3401.)

 

Acquisition a growing focus in medtech

Yesterday, we commented on top 10 medical innovations reported at the Cleveland Clinic Innovation Summit.  

At the summit, Boston Scientific CEO Jim Tobin’s presentation underscored the other point we made recently, that acquisition is a routine part of medtech’s drive for innovation.  Boston Scientific has some $2 billion on hand and is looking for companies whose products can contribute to top line growth, underscoring that startups with a more future potential are less of interest.  The operative consideration is that revenues in the near term are important for Boston Scientific, as it recuperates from its expensive acquisition of Guidant.  Tobin’s presentation was well described here.

 

Med-Tech Buyout Targets, Sun Rises in East

This article in Forbes is interesting for its stranglehold on the obvious.

Noting that the shares of surgical device maker, Cardica, and gene therapy device maker, Cardium Therapeutics, have fallen of late, making them potential acquisition targets which, of course, virtually all med-tech companies are anyway. In fact, and to give Forbes credit, their point is that the companies’ limited access to cash will impede them from being acquisition targets by larger companies.

The nature of the medical device industry now, and probably for some time to come, is such that small startups or development phase device companies represent a vital source of innovation that make them ripe pickings for the well-established medtech companies. And, clearly, it isn’t even the small or early stage companies that are such targets — no one should need to be reminded of the battle-royale between J&J and Boston Scientific over the acquistion of the not-so-early-stage-or-small Guidant, said battle being “won” by Boston Scientific.

Indeed, I would venture that it is the minority of medical device company entrepreneurs who have the vision, desire and fortitude to make the IPO their ultimate goal. Innovating, developing and gaining regulatory approval for market introduction of devices is a very different different beast than commercializing a device through even a limited geographic scale, let alone worldwide.

Ablation: Radiofrequency Among Big Growth Segments in Surgery

The surgical ablation of soft tissues will see significant growth in the next few years and, among them, radiofrequency will demonstrate some of the most significant growth.  Other modalities include hydromechanical, microwave, thermal, cryotherapy, ultrasound, light, radiation and electrical.  Growth in these ablation segments in the U.S. is shown in the chart below.

Source:  MedMarket Diligence Report #A125, “Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities.”

 

Radio frequency (RF) used in ablation is created by a stimulated electromagnetic emission process. When a resonant radio frequency energy flow is established between two reflectors, an intervening ionized medium stimulates and maintains the resonant radio energy flow. A number of companies are developing and marketing products around this modality; key companies, their products and applications are shown below.

Radiofrequency energy is gaining widespread use in the field of sports medicine surgery for the thermal modification of soft tissue structures within the joint. The use of radiofrequency energy for thermal chondroplasty has gained tremendous popularity because of the quality of the therapy. Radiofrequency surgical systems have the inherent ability to seal large vessels as a result of the tremendous temperatures the energy can generate.


Ablation technologies products, manufacturers and markets are detailed in the worldwide report #A125, “Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities.” The report may be ordered for immediate download online or may be purchased via Google Checkout, below.

 

 

Optimism: perception and reality in healthcare, elsewhere

Forgive this less-than-medtech-relevant sidebar on the wild swings of optimism, pessimism, hope and fear. Perhaps, all things being equal, the simplest explanation is the right one.

Like Tom Hanks’ character in the movie “Big”, when he puts up his hand and says, “I don’t get it” (in his case a toy building that turns into a robot), I seriously struggle with the prospect of an economic downturn — I just don’t get it.

One could easily look at healthcare, as we have argued many times in the past, and conclude that it is a special case, an industry that is insensitive to recession (disease knows know bear market). Clearly this is the case, as I review hundreds of product approvals, patents, market introductions and other activity that stand as testimony to the juggernaut of the healthcare industry, seemingly rolling over as it does through every economic obstacle (save, almost, the VC cash crunch).

I just don’t get the self-fulfilling prophecies of Wall Street and elsewhere in which perception becomes reality. We have only to fear fear itself, said FDR. Because we think the market may go down, we sell our shares and, guess what, the market goes down.

I do not deny the hard reality that many of us (mortgage holders, banks) overspent our means and need to cut back, but in the scheme of the world, correcting this should be a marginal adjustment, should it not? Every one of us needs to get up every day, eat meals, take kids to school and do the myriad activities of life that, like healthcare, just don’t change. Shouldn’t that drive the world and the world markets? Why are thousands and thousands now out of work?

Or is it really that the world of investment exerts a hyperbolic pull on all of us, up and down, inflating and deflating the real values of our daily lives. Because someone wants to make money, their investment drives up value, and because someone desperately fears losing money, their panic drives down value.

And, yet, every day we get up and still need to live, still need to eat, have a roof over our heads, clothes on our backs.

Accuse me of being simplistic, but I don’t get it.

The Dow is up 900 points, the Dow is down 500 points, down 200 points, down 200 points. What happened? Did the world really gain or lose 900 points in value?

It’s insane and I don’t get it, so I refuse to accept it. My value — and every thing I value — has not changed.